“…Finally, with the demonstrated robustness, beyond the current COVID-19 pandemic, eSIREN could be further expanded for accessible detection of other infectious diseases and improved patient stratification in resource-limited settings ( Wu et al, 2020 ; Zhu et al, 2019 ). Technical improvements, through the integration of advanced microfluidics ( Morikawa et al, 2020 ; Choi et al, 2019 ; Siedlik et al, 2021 ; Zhao et al, 2019 ) and arrayed sensor configuration ( Lim et al, 2019 ; Jeong et al, 2019 ), could facilitate highly-parallel and large-scale testing.…”